Back
RaySearch Laboratories AB Vs. Hansa Biopharma AB Industry Stock Comparison
Buy
83
RSLBF
RaySearch Laboratories AB
Last Price:
19.09
Seasonality Move:
2.39%
Sell
39
HNSBF
Hansa Biopharma AB
Last Price:
2.83
Seasonality Move:
-0.32%
Buy
83
RaySearch Laboratories AB (RSLBF)
is a Buy
Is RaySearch Laboratories AB a Buy, Sell or Hold?
- The current RaySearch Laboratories AB [RSLBF] share price is $19.09. The Score for RSLBF is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- RSLBF is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy, Sell or Hold?
- The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RSLBF Stock Price Chart
What is RaySearch Laboratories AB's stock price today?
-
The RaySearch Laboratories AB share price today is $19.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSLBF is experiencing slight buying pressure.
HNSBF Stock Price Chart
What is Hansa Biopharma AB's stock price today?
-
The Hansa Biopharma AB share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.
RSLBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.7 | Buy |
| Relative Strength Index (14 RSI): | 97.41 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.95 - 18.81) | Buy |
| Bollinger Bands (100): | (14.24 - 17.2) | Buy |
HNSBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 8.68 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.1 - 3.8) | Sell |
| Bollinger Bands (100): | (2.81 - 3.47) | Sell |
RSLBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.81 | Buy |
| 20-day SMA: | 18.19 | Buy |
| 50-day SMA: | 16.75 | Buy |
| 200-day SMA: | 13.27 | Buy |
| 8-day EMA: | 18.82 | Buy |
| 20-day EMA: | 18.18 | Buy |
| 50-day EMA: | 17.08 | Buy |
| 200-day EMA: | 13.88 | Buy |
HNSBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.04 | Sell |
| 20-day SMA: | 3.4 | Sell |
| 50-day SMA: | 3.35 | Sell |
| 200-day SMA: | 3.05 | Sell |
| 8-day EMA: | 3.01 | Sell |
| 20-day EMA: | 3.26 | Sell |
| 50-day EMA: | 3.31 | Sell |
| 200-day EMA: | 3.65 | Sell |
RaySearch Laboratories AB Earnings Growth & RSLBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
RaySearch Laboratories AB Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Hansa Biopharma AB Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||